INTRODUCTION
Tetanus toxin (TeNT) and the botulinum toxins (BoNTs) are extremely potent neurotoxins produced by the anaerobic bacteria, C. tetani and C. botulinum respectively.
The toxins are structurally and functionally related, each being synthesized as a 150kDa single polypeptide that is subsequently proteolytically cleaved to give a 50kDa aminoterminal L-chain, disulfide bonded to a 100kDa carboxyl-terminal H-chain (1, 2) . The Lchain has a metalloprotease activity and is responsible for the toxicity (3) . The heavy chain can be cleaved into two fragments, H N and H C . Each fragment is thought to have a distinct function, the H C fragment for binding to sensitive cells and subsequent internalisation into vesicles (4) (5) (6) , and the H N fragment for the translocation of the Lchain across the vesicular membrane (4, 7) . Although tetanus and botulinum toxins bind at the nerve terminals of the neuromuscular motor junction (NMJ) they exhibit different clinical symptoms. BoNTs act locally at the peripheral nervous system by disrupting neurotransmitter release and causing flaccid paralysis. In contrast, TeNT activity occurs at the central nervous system, following retrograde transport from the axon terminal to inhibitory neurons within the spinal cord. Proteolytic cleavage of VAMP by TeNT Lchain blocks neurotransmitter release (3) , by preventing formation of the synaptic SNARE complex (8) .
A two receptor-model incorporating ganglioside and protein receptors has been proposed to explain the distinct sites of action of TeNT and BoNTs (5, 9, 10) . These models attempt to explain the experimental observations that are largely inconsistent with a sole ganglioside receptor, such as the difference in the binding affinity measured in vivo (10 M) (5, 11, 12) and the low and high affinity sites that have been measured in rat brain membranes (13, 14) . Although synaptotagmin in combination with gangliosides has been shown to act as a receptor for BoNT/A, B and E (15) (16) (17) characterization of the protein receptors for other toxins is extremely limited. A putative receptor for TeNT has been described, but the protein(s) remain to be characterised at the molecular level (9, 10) .
Ganglioside molecules are a class of glycosphingolipids found in high percentages in the membranes of neuronal cells (18) . Most of them contain a common 'core' (GM1 ganglioside) consisting of Gal(β1-3)GalNAc(β1-4)(NeuAc(α2-3))Gal(β1-4)Glc(β1-1)Cer to which one or more N-acetyl-neuraminic acids (sialic acids) are bound (18) (Fig.   1a ). They were the first membrane component found to have BoNT and TeNT binding activity (19) (20) (21) . Later studies have identified the gangliosides of series b, especially GT1b ( Fig. 1a) and GD1b, to have the highest affinity (11, (22) (23) (24) (25) (26) . Binding studies of
TeNT to brain membranes and purified gangliosides have shown that the Gal(β1-3)GalNAc(β1-4)(NeuAc(α2-8) NeuAc(α2-3))Gal(β1-4) moiety (i.e. Gal4-GalNAc3-Sia7-Sia6-Gal2 in Fig. 1a) is essential for the binding of TeNT or H C fragment (22, 23) .
The X-ray crystal structure of the H C fragment (27, 28) shows that the protein has two domains. The amino-terminal domain has a jelly-roll lectin-like fold and the carboxylterminal is a β-trefoil. The C-terminal domain of the heavy chain of BoNT/A (29) has been shown to have a similar structure. Biochemical and mutational studies (4, 6, 30) with TeNT and native and recombinant H C fragments have shown that the β-trefoil domain of (31) . Our own studies on the crystal structure of TeNT H C complexed with lactose (Gal(β1-4)Glc)) supports this association (28). Further structural studies on H C crystals soaked in solutions containing the carbohydrate units of gangliosides (galactose, Nacetyl-galactosamine and sialic acid) (28), identified three more areas where the monomer sugar units bound. These results suggested that additional sites on the H C molecule may be involved in recognition of ganglioside receptors and that a single ganglioside could bind simultaneously to more than one TeNT molecule. Our attempts to crystallise a complex between TeNT H C and native GT1b ganglioside have not been successful. However crystals could be grown of a complex formed between TeNT H C and a synthetic GT1b analogue. This analogue has the ceramide replaced by a 2-(trimethylsilyl)ethyl group and a β2-3 linkage from the disialic acid arm to the central galactose unit i.e. Sia6 is the β-anomer (Fig. 1b) . The crystal structure of this complex shows cross-linking between the GT1b analogue and TeNT H C. 
MATERIALS AND METHODS
Ganglioside synthesis  The fully protected derivative of GT1b oligosaccharide (290 mg), compound 27 in Ishida et al. (32) , was converted into the desired product (87 mg, 53% in three steps), by hydrogenolytic removal of benzyl groups over Pd-C catalyst, de-O-acylation with sodium methoxide in methanol and subsequent saponification of methyl esters and lactone group by treatment with 0.2 M KOH. The product was purified using a Sephadex LH-20 (MeOH) column.
Protein expression and purification  TeNT H C protein was prepared from E. coli BL21 (pKS1) by induction with IPTG to 1mM for 4 hours as described by Sinha et al. (33) .
Cells were then harvested, lysed by sonication and the H C protein purified by nickel affinity chromatography using Ni-NTA resin (Qiagen, Crawley, Sussex, UK) followed by gel-filtration on a Superdex-200 column. The protein was concentrated to 2.8mg/ml using a 30K cutoff Microcep TM microconcentrator (Pal GelmanSciences) pretreated overnight with 10% glycerol to prevent non-specific interactions of protein with the membrane.
Crystallization  Protein (2.8 mg/ml) and the GT1b analogue (GT1b-βA) were mixed in a range of final molar ratios (1:2 to1:10). Crystals were produced from all mixtures by vapour diffusion against a 1ml reservoir solution containing either 20% PEG 4K and 0.2M imidazole-malate pH=7.0 or 20% PEG8K, 0.2 M Na 2 KPO 4 and 0.1 M TRIS (pH=8.5) using a sitting drop containing 2 µl of the H C +heptasaccharide solution and 2 µl of reservoir solution.
After a few days, plate-like crystals (thickness less than 10 µm) grew in the first conditions and rod-like crystals (thickness about 50 µm) in the second conditions. X-ray diffraction data from the plate-like crystals were collected at the ESRF microfocus with a Mar240 image plate detector set at a distance of 173mm from the crystal. An exposure at a 10000 dose per frame and angular interval of 1º was used. 173 frames were collected from a single crystal. All data sets were collected under cryo-cooling conditions (100K). The crystals were placed briefly in a well of cryo-protectant (15% PEG 400) then collected in a loop and flash-cooled in a stream of dry nitrogen at 100K. Both crystal forms were monoclinic, space group P2 1 , but the a cell dimension was doubled in the plate-like crystals, which contain two molecules in the asymmetric unit as a consequence. Table 1 shows the data statistics.
Crystal structure determination  For both crystal forms, molecular replacement was performed using AMoRe (34) with the H C coordinates of the lactose-H C complex (PDB access code 1dll) (28) as the search model. After rigid body refinement of the protein (both crystal forms), several cycles of refinement using Refmac (35) and rebuilding with QUANTA, the carbohydrate ligand was modelled into weighted difference electron density (2mFo-DFc and mFo-DFc) maps (Fig. 2) . Omit maps were used for building ambiguous areas. The initial model and the restraints dictionary for the carbohydrate Table 1 by guest on September 1, 2017 http://www.jbc.org/ Downloaded from 9 were generated using coordinates for the monosaccharide units of the ligand taken from the Cambridge Structural Database (CSD) and the Protein Data Bank. β-neuraminic acid (CSD code ANEU) was used for the β-anomeric sialic acid, N-acetyl-β-galactosamine (CSD code AOGAPY) for N-acetyl-galactosamine, β-lactose (CSD code BLACTO) for galactose and glucose and coordinates for α-anomeric sialic acid were taken from the structure of the complex of cholera toxin with GM1 ganglioside PDB ID 2chb (36) .
Further rebuilding and refinement proceeded using QUANTA, Refmac (35) , and ARP (37) . The protein structure geometry was analysed using PROCHECK (38) . Buried surfaces were calculated using GRASP(39) with a 1.4Å probe radius.
The initial 3D-model of GT1b-OS was constructed with the SWEET software (40) and superimposed on the GT1b-βA structure using LSQKAB (41). The fit was improved with cycles of manual adjustment to the glycosidic torsion angles of the GT1b-OS (QUANTA) followed by superposition with LSQKAB. Excluding Sia6, the rms difference between the overlapped oligosaccharides is 1.3Å. No energy minimisation was performed.
The figures were prepared using SETOR (42) and GRASP (39) and were edited and composed using the GIMP (http://www.gimp.org/). 
Gal4-GalNAc3 binding site
The Gal-GalNAc binding site is a narrow groove formed by the side chains of residues Trp1289 and His1271 with Tyr1290 forming the base (Fig. 6a) . On one side of the groove, Trp1289 packs against His1293, while on the other His1271 packs against Phe1218. A hydrogen bond (3.5Å in molecule A; 3.4Å in molecule B; 3.5 Å in molecule 
Carbohydrate conformation
The φ and ψ angles of the glycosidic bonds of the oligosaccharide molecule are listed in Table 3 . The Gal4(β1-3)GalNAc3 and GalNAc3(β1-4)Gal2 glycosidic bonds, given the resolution of the structure, appear to be relatively flexible, as observed in the NMR structure of the similar GD1b ganglioside (46) . The values of the Sia5(α2-3)Gal4, and Sia7(α2-8)Sia6 angles lie in minima predicted by theoretical calculations (47) . There are intra-carbohydrate hydrogen bonds (Table 2 ) and water mediated ones, but as they are not present in all copies, we believe they are not critical in determining the conformation of GT1b-βA. 
Comparison with the H C -Lac, NGA, Sia soaks

Comparison with other glycosphingolipid binding toxins.
Cholera toxin and shiga-like toxin are glycosphingolipid-binding toxins where structural data are available for the proteins complexed with their carbohydrate receptors. The cholera toxin receptor, ganglioside GM1, is similar to GT1b (Fig.1 ) but lacks the two terminal sialic acids (Sia5 and Sia7 in Fig. 1a ). In contrast with the two ganglioside sites in TeNT, in cholera toxin (36) there is one binding site in each of the five β-subunits, with the terminal galactose and sialic acid forming the main interactions. This is very similar to the TeNT H C -GT1b-βA interactions where the galactose Gal4 and disialogroup Sia7-Sia6 (Fig. 1) 
Discussion
The crystal structure of a complex between the H C fragment of TeNT and a synthetic analogue of GT1b reported here provides the first direct structural evidence of the interaction between the protein toxin and ganglioside. The observation of two separate binding sites on both the protein and carbohydrate components is unexpected, but nonetheless demonstrates the specificity of the interaction and is consistent with published biochemical data. Similar interactions were described in our earlier report of the crystal structures of TeNT H C soaked with lactose, N-acetyl-galactosamine and sialic acid (28).
These structural data demonstrate that two sites on the GT1b molecules, the Gal4-GalNAc3 and Sia7-Sia6 groups, provide the key interactions for the TeNT-ganglioside recognition. The results are entirely consistent with the similar binding affinites observed for GT1b and GD1b gangliosides (22, 23) which differ only in GT1b possessing a terminal sialic acid on the GalNAc3 unit. The structure shows no significant interaction between this terminal sialic acid (Sia5) and the H C fragment. In contrast, the extensive interactions of the terminal sialic acid (Sia7) with the H C fragment explain why in GM1, which lacks this sugar, the affinity of the binding is considerably lower (1, 2, 23, 24) . Recent biochemical characterisations of mutant H C molecules are consistent with this structure (33, 52) . Mutant H C containing a deletion of residues 1214-1219 is severely impaired in its ability to bind GT1b, having 0. Similar effects explain the mutagenesis data of Halpern and Loftus (6) who showed that deletion of the C-terminal 5 or 10 residues reduced binding to both ganglioside GT1b and to primary spinal cord neurones. These residues do not interact with the GT1b analogue, and the reduction in ganglioside binding is probably due to alteration in the structure or stability of the H C molecule.
Simultaneous binding through both groups on the ganglioside involves more than one protein molecule and suggests that crosslinking might occur in vivo. This would depend on the membrane-attached, wild-type gangliosides making the same interactions as in the crystal complex. The carbohydrate of the synthetic ganglioside used in this work differs from that of wild-type GT1b only in the Sia6-Gal2 linkage which is α-in the wild-type and β-in this work (Fig. 1) . This difference will not affect the binding of the Gal-GalNAc (Fig. 8) . A model of GT1b-OS can be fitted to the structure of GT1b-βA to retain the cross-linking found in the crystal, and with the formation of the same H-bonds and salt bridge between Sia7 and the protein. There are no steric clashes in this model.
The biological consequences of multivalent crosslinking would be to increase the binding affinity of the protein to the ganglioside and to induce a clustering of the toxin on the cell surface. Indeed binding of TeNT to the cell surface is characterised by punctate staining in a variety of neuronal cells types, including rat dorsal root ganglia (30) and mouse spinal cord neurons (4, 25) . While this punctate staining has been inferred (4) to reflect The independent protein molecules are coloured in green and claret, GT1b-βA is yellow and the model of GT1b-OS is blue. The red ellipse identifies the differences in orientation of Sia6 resulting from the different Sia6-Gal2 anomeric links. 
Where I(h) is the mean intensity for reflection h, after rejection of outliers. All data were included in the structure refinements. These residues belong to a symmetry related protein molecule. Figure 1 by guest on 
